Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19.

[1]  M. Hall,et al.  Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19 , 2020, ACS central science.

[2]  V. Sengupta,et al.  Exosomes Derived From Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19. , 2020, Stem cells and development.

[3]  R. Razonable,et al.  Treatment Considerations for COVID-19 , 2020, Mayo Clinic Proceedings.

[4]  G. Lippi,et al.  Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis , 2020, Current Problems in Cardiology.

[5]  P. Mitra,et al.  COVID-19 Pandemic in India: What Lies Ahead , 2020, Indian Journal of Clinical Biochemistry.

[6]  M. Hall,et al.  Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19 , 2020 .

[7]  Stefano Volpi,et al.  On the Alert for Cytokine Storm: Immunopathology in COVID‐19 , 2020, Arthritis & rheumatology.

[8]  Wei Zhou,et al.  Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor , 2020, Pharmacological Research.

[9]  A. Ardeshirylajimi,et al.  Mesenchymal Stem Cell Therapy for COVID-19: Present or Future , 2020, Stem Cell Reviews and Reports.

[10]  X. Jouven,et al.  Denominator matters in estimating COVID-19 mortality rates , 2020, European heart journal.

[11]  Xiaotao Lu,et al.  An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice , 2020, Science Translational Medicine.

[12]  M. Zhang,et al.  Psychological symptoms among frontline healthcare workers during COVID-19 outbreak in Wuhan , 2020, General Hospital Psychiatry.

[13]  S. Bavari,et al.  A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19) , 2020, The American journal of tropical medicine and hygiene.

[14]  N. Ford,et al.  Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment , 2020, Journal of the International AIDS Society.

[15]  S. Chatterjee.  Understanding the Nature of Variations in Structural Sequences coding for Coronavirus Spike, Envelope, Membrane and Nucleocapsid Proteins of SARS-CoV-2 , 2020 .

[16]  Y. Ho,et al.  SARS-CoV-2: A Storm is Raging. , 2020, The Journal of clinical investigation.

[17]  M. Cascella,et al.  Features, Evaluation and Treatment Coronavirus (COVID-19) , 2020 .

[18]  Sandro G. Viveiros Rosa,et al.  Clinical trials on drug repositioning for COVID-19 treatment , 2020, Revista panamericana de salud publica = Pan American journal of public health.

[19]  A. Mishra,et al.  Latest updates on COVID‐2019: A changing paradigm shift , 2020, Journal of medical virology.

[20]  S. Rozelle,et al.  Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review , 2020, Infectious Diseases of Poverty.

[21]  Brandon Michael Henry,et al.  COVID-19, ECMO, and lymphopenia: a word of caution , 2020, The Lancet Respiratory Medicine.

[22]  C. Caruso,et al.  Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia , 2020, Aging and disease.

[23]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[24]  Yuan Shi,et al.  Convalescent plasma as a potential therapy for COVID-19 , 2020, The Lancet Infectious Diseases.

[25]  B. Pan,et al.  Understanding of COVID‐19 based on current evidence , 2020, Journal of medical virology.

[26]  R. Terracciano,et al.  Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives , 2020, Expert review of respiratory medicine.

[27]  A. Zohaib,et al.  Structural modeling and conserved epitopes prediction against SARS-COV-2 structural proteins for vaccine development , 2020 .

[28]  D. Heymann,et al.  COVID-19: what is next for public health? , 2020, The Lancet.

[29]  Yi-Chi Wu,et al.  The outbreak of COVID-19: An overview , 2020, Journal of the Chinese Medical Association : JCMA.

[30]  Yi-Chi Wu,et al.  The outbreak of COVID-19: An overview , 2020, Journal of the Chinese Medical Association : JCMA.

[31]  P. Zha,et al.  Treatment Strategies for Reducing Damages to Lungs In Patients with Coronavirus and Other Infections , 2020 .

[32]  P. Hsueh,et al.  Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV , 2020, Journal of Microbiology, Immunology and Infection.

[33]  Tiantian Han,et al.  Coronavirus infections and immune responses , 2020, Journal of medical virology.

[34]  Qianyun Liu,et al.  Emerging coronaviruses: Genome structure, replication, and pathogenesis , 2020, Journal of medical virology.

[35]  A. Şahin.  2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature , 2020 .

[36]  N. Kosaka,et al.  MSC-exosomes in regenerative medicine , 2020 .

[37]  P. Rocco,et al.  The potential of mesenchymal stem cell therapy for chronic lung disease , 2020, Expert review of respiratory medicine.

[38]  Y. Jang,et al.  Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis , 2019, Journal of microbiology and biotechnology.

[39]  Jae W. Lee,et al.  Mesenchymal Stem Cell–Derived Extracellular Vesicles Decrease Lung Injury in Mice , 2019, The Journal of Immunology.

[40]  D. Offen,et al.  Intranasal Delivery of Mesenchymal Stem Cell Derived Exosomes Loaded with Phosphatase and Tensin Homolog siRNA Repairs Complete Spinal Cord Injury. , 2019, ACS nano.

[41]  A. Corsico,et al.  Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration , 2019, Cells.

[42]  A. Tesei,et al.  The Role of Mesenchymal Stem Cells in Radiation-Induced Lung Fibrosis , 2019, International journal of molecular sciences.

[43]  P. Wallace,et al.  IL12 and IFNγ secretion by donor mononuclear cells in response to host antigens may predict acute GVHD after HSCT. , 2019, Immunobiology.

[44]  Zhong Chen,et al.  Mesenchymal stromal cells‐derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti‐apoptotic miR‐21‐5p , 2019, European journal of pharmacology.

[45]  R. Hass,et al.  Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells , 2019, Cancers.

[46]  Hai-dong Guo,et al.  RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer’s disease , 2019, Immunity & Ageing.

[47]  Lanjuan Li,et al.  Modulating autophagy in mesenchymal stem cells effectively protects against hypoxia- or ischemia-induced injury , 2019, Stem Cell Research & Therapy.

[48]  Chibuike C. Udenigwe,et al.  Naturally Occurring Exosome Vesicles as Potential Delivery Vehicle for Bioactive Compounds , 2019, Front. Sustain. Food Syst..

[49]  E. Zuba-Surma,et al.  Challenges and Controversies in Human Mesenchymal Stem Cell Therapy , 2019, Stem cells international.

[50]  R. Zhao,et al.  Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm , 2019, Biomarker Research.

[51]  S. Lim,et al.  Mesenchymal stem cell exosomes enhance periodontal ligament cell functions and promote periodontal regeneration. , 2019, Acta biomaterialia.

[52]  W. Drobyski,et al.  Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease , 2019, Front. Immunol..

[53]  C. Su,et al.  Design strategies and application progress of therapeutic exosomes , 2019, Theranostics.

[54]  M. Rojas,et al.  Preclinical Evidence for the Role of Stem/Stromal Cells in Targeting ARDS , 2019, Stem Cell-Based Therapy for Lung Disease.

[55]  Junyong Wu,et al.  Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer. , 2019, Acta biomaterialia.

[56]  Y. Takakura,et al.  Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application. , 2018, Biological & pharmaceutical bulletin.

[57]  Wenwan Zhong,et al.  Highly Efficient Exosome Isolation and Protein Analysis by an Integrated Nanomaterial-Based Platform. , 2018, Analytical chemistry.

[58]  Myung Soo Kim,et al.  Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations. , 2018, Nanomedicine : nanotechnology, biology, and medicine.

[59]  J. Lorente,et al.  New insights into the mechanisms of pulmonary edema in acute lung injury. , 2018, Annals of translational medicine.

[60]  Kun Zhang,et al.  Focus on Mesenchymal Stem Cell-Derived Exosomes: Opportunities and Challenges in Cell-Free Therapy , 2017, Stem cells international.

[61]  Dong-Myung Shin,et al.  Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway , 2017, Experimental & Molecular Medicine.

[62]  S. Jay,et al.  Preservation and Storage Stability of Extracellular Vesicles for Therapeutic Applications , 2017, The AAPS Journal.

[63]  Pieter Vader,et al.  Extracellular vesicles for drug delivery. , 2016, Advanced drug delivery reviews.

[64]  Claire Heichette,et al.  Trehalose prevents aggregation of exosomes and cryodamage , 2016, Scientific Reports.

[65]  M. Banach,et al.  Exosomes as nanocarriers for siRNA delivery: paradigms and challenges , 2016, Archives of medical science : AMS.

[66]  Parvin Akbarzadehlaleh,et al.  Mesenchymal Stem Cell-Derived Exosomes: New Opportunity in Cell-Free Therapy. , 2016, Advanced pharmaceutical bulletin.

[67]  Ashish Kumar Agrawal,et al.  Exosomal formulation enhances therapeutic response of celastrol against lung cancer. , 2016, Experimental and molecular pathology.

[68]  Joshua L Hood.  Post isolation modification of exosomes for nanomedicine applications. , 2016, Nanomedicine.

[69]  H. Duan,et al.  From structures to functions: insights into exosomes as promising drug delivery vehicles. , 2016, Biomaterials science.

[70]  A. Monsel,et al.  Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases , 2016, Expert opinion on biological therapy.

[71]  Zhe Wang,et al.  Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy , 2016, Human vaccines & immunotherapeutics.

[72]  M. Ciuffreda,et al.  Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair. , 2016, Methods in molecular biology.

[73]  M. Gnecchi.  Mesenchymal Stem Cells , 2016, Methods in Molecular Biology.

[74]  M. Matthay,et al.  Microvesicles Derived From Human Mesenchymal Stem Cells Restore Alveolar Fluid Clearance in Human Lungs Rejected for Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[75]  Wei Wang,et al.  Mesenchymal stem cells abrogate experimental asthma by altering dendritic cell function , 2015, Molecular medicine reports.

[76]  M. Epple,et al.  MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease , 2014, Leukemia.

[77]  Samuel A Wickline,et al.  Maximizing exosome colloidal stability following electroporation. , 2014, Analytical biochemistry.

[78]  B. Yu,et al.  Exosomes Derived from Mesenchymal Stem Cells , 2014, International journal of molecular sciences.

[79]  M. Matthay,et al.  Human Mesenchymal Stem Cell Microvesicles for Treatment of Escherichia coli Endotoxin‐Induced Acute Lung Injury in Mice , 2014, Stem cells.

[80]  Changjin Lee,et al.  Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary Hypertension , 2012, Circulation.

[81]  M. Wood,et al.  Exosome nanotechnology: An emerging paradigm shift in drug delivery , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[82]  Robert Peach,et al.  Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection , 2011, Cell.

[83]  Hugh Rosen,et al.  Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus , 2011, Proceedings of the National Academy of Sciences.

[84]  M. Edwards,et al.  The Airway Epithelium: Soldier in the Fight against Respiratory Viruses , 2011, Clinical Microbiology Reviews.

[85]  Gerard Pasterkamp,et al.  Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. , 2010, Stem cell research.

[86]  David A. Bader,et al.  Facial Expression Recognition System using Statistical Feature and Neural Network , 2012 .